Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Late-breaking trial of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: ESPRIT, PARAGON B, and Second Symphony Series

Late-breaking trial of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: ESPRIT, PARAGON B, and Second Symphony Series. Pfeffer MA, series editor. Cardiology Scientific Update. 2000.


© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.